RECKITT BENCKISER

Reckitt Benckiser (RB) is one of the world leaders in the manufacture of household goods, pharmaceuticals, health and hygiene products.

The company's credo is to create modern innovative solutions for a healthy life in homes full of joy and comfort.

The company's portfolio consists of 19 key brands, each of which holds leading positions in its category.

RB is represented in Ukraine by such well-known brands as:

Nurofen®, Strepsils®, Gaviscon® - in the direction of medicines;

Durex®, Contex®, Veet®, Clearasil®, Scholl® - towards health and hygiene products;

Finish®, Airwick®, Vanish®, Calgon®, Harpic®, Bang® - towards home furnishings.

The key to the company's success is the professionalism of employees and adherence to corporate values. It is the unique combination of a focus on a successful business and a desire to achieve more that helps the company achieve high results in all areas of its activities.

RB core values:

Achievements

Entrepreneurship

Cooperation

A responsibility

RB was created in 1999 as a result of the merger of Reckitt & Colman and Benckiser N.V., founded in the first half of the 19th century.

Today RB is a multinational company employing about 36,000 professionals in more than 200 countries. The company's production facilities are located in 60 countries, and the main offices are in the UK, Singapore, UAE (Dubai) and Holland (Amsterdam).

RB products are successfully sold in 200 countries around the world.

In 2010, RB was named the Health & Household sector by Britain's Most Admired Companies Awards 2010.

In 2008, RB was ranked among the TOP-40 SDSI (Safer Detergents Stewardship Initiative), the leading companies in the production of environmentally friendly products, according to the US EPA (Environmental Protection Agency).

RB commercial office in Ukraine was opened in 2006. Today RECKITT BENKIZER HOUSEHOLD END HEALTH CARE UKRAINE LLC successfully operates in 3 business areas: medicines, health and hygiene products, household products. The company employs up to 300 people.